Length of Stay and Cost of Pediatric Readmissions

Jessica L Markham1, Matt Hall2,3, James C Gay4

  • 1Division of Pediatric Hospital Medicine, Children's Mercy Kansas City and Department of Pediatrics, University of Missouri-Kansas City School of Medicine, Kansas City, Missouri; jlmarkham@cmh.edu.

Pediatrics
|March 11, 2018
PubMed

Insights

Pediatric 30-day readmissions double hospital length of stay and triple costs. Higher costs occur when children are readmitted to a different hospital, highlighting the need to track total episode of care metrics.

Area of Science:

  • Pediatric healthcare research
  • Health services research
  • Hospital readmission analysis

Background:

  • Hospital readmissions represent a significant burden on healthcare systems.
  • Understanding the duration and financial impact of pediatric readmissions is crucial.
  • This study addresses the knowledge gap regarding length of stay and costs for 30-day readmissions in children.

Purpose of the Study:

  • To nationally assess the length of stay (LOS) and associated costs for 30-day readmissions in pediatric patients.
  • To compare the episode of care LOS and costs for readmitted children versus non-readmitted children.
  • To investigate variations in LOS and costs based on medical condition and readmission hospital.

Main Methods:

  • Retrospective analysis of the 2013 Nationwide Readmissions Database.
  • Utilized generalized linear mixed effects models for statistical analysis.
  • Adjusted for key clinical and demographic factors to evaluate LOS and costs.

Main Results:

  • Over 125,000 children (4.5%) experienced a 30-day readmission.
  • Readmitted children had double the episode LOS (5.8 vs 2.9 days) and 2.3 times higher total costs ($12,250 vs $5,340).
  • Readmissions to different hospitals incurred higher episode of care costs, though LOS was similar.

Conclusions:

  • Pediatric readmissions significantly increase hospital length of stay and healthcare expenditures.
  • The financial impact is particularly pronounced when readmissions occur at a different facility.
  • Metrics for readmissions should encompass total LOS and costs for the entire episode of care.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
279
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
334
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
247
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
311
Social Exchange Theory02:06

Social Exchange Theory

We have discussed why we form relationships, what attracts us to others, and different types of love. But what determines whether we are satisfied with and stay in a relationship? One theory that provides an explanation is social exchange theory. According to social exchange theory, we act as naïve economists in keeping a tally of the ratio of costs and benefits of forming and maintaining a relationship with others (Rusbult & Van Lange, 2003).
40.8K
Solution Concentration and Dilution02:59

Solution Concentration and Dilution

The relative amount of a given solution component is known as its concentration. Often, though not always, a solution contains one component with a concentration that is significantly greater than that of all other components. This component is called the solvent and may be viewed as the medium in which the other components are dispersed or dissolved. Solutions in which water is the solvent are, of course, very common on our planet. A solution in which water is the solvent is called an aqueous...
135.3K